Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03180073 · ClinicalTrials.gov registry record
Conduction Abnormalities With Severe Aortic Stenosis Before and After Transcatheter Aortic Valve Replacement
A clinical trial, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- 100
- Enrollment target
NCT03180073: Completed study, sponsored by The Cleveland Clinic.
NCT03180073 is a clinical trial that has completed, run by The Cleveland Clinic. The registered enrollment target is 100 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03180073 has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
Study Summary
Most of the conduction abnormalities with TAVR are usually detected during the procedure or during the following days of observation. Little is known about the prevalence and timing of any conduction abnormalities that exist before (other than standard ECG) or after through long term cardiac monitoring.
Primary Outcome
the prevalence of brady arrhythmia (Sinus brady, Sinus Pauses, AV Block, Bundle Branch Block) among patients with severe aortic stenosis who undergo TAVR using an extended cardiac rhythm monitor (Zio Patch) and determine if the brady arrhythmias predict the need for a pacemaker.
Interventions
- DIAGNOSTIC_TEST Ziopatch Pre discharge
- DIAGNOSTIC_TEST Ziopatch at Discharge
- DIAGNOSTIC_TEST Ziopatch at 2 months
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2017-06-06 |
| Est. Completion | 2020-12-23 |
What the finished NCT03180073 record still lists
NCT03180073 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 3 interventions - of which Ziopatch Pre discharge is the first listed.
NCT03180073 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03180073 about?
NCT03180073 is a clinical study titled "Conduction Abnormalities With Severe Aortic Stenosis Before and After Transcatheter Aortic Valve Replacement". Most of the conduction abnormalities with TAVR are usually detected during the procedure or during the following days of observation. Little is known about the prevalence and timing of any conduction abnormalities that exist before (other than standard ECG) or after through long term cardiac monitor...
What is the current status of trial NCT03180073?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2017-06-06. Estimated completion is 2020-12-23.
What interventions are being tested in trial NCT03180073?
The interventions under investigation include: Ziopatch Pre discharge (DIAGNOSTIC_TEST), Ziopatch at Discharge (DIAGNOSTIC_TEST), Ziopatch at 2 months (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03180073?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI